InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Edgewise Therapeutics, Inc.

EWTX Clue Score35
United States Fiscal year ends December CIK 0001710072 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
R Michael Carruthers
11 Oct 2024
Chief Financial Officer
Exercised, kept
70,000
$0.71
$49.70K
R Michael Carruthers
22 Jun 2023
Chief Financial Officer
Exercised, kept
10,000
$0.71
$7.10K
R Michael Carruthers
23 May 2022
Chief Financial Officer
Exercised, kept
9,000
$0.71
$6.39K
John R Moore
21 Jan 2022
General Counsel
Exercised, kept
5,400
$0.71
$3.83K
John R Moore
28 Dec 2021
General Counsel
Exercised, kept
5,400
$0.71
$3.83K
Alan J Russell
30 Nov 2021
Chief Scientific Officer
Exercised, kept
25,000
$0.45
$11.25K
Alan J Russell
30 Nov 2021
Chief Scientific Officer
Exercised, kept
147,585
$0.18
$26.57K
Show all 172 transactions →

What was left out

Form 4 filings counted 174
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 83
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 43,853,801
Sales filed before the plan box existed 37
History held since 30 Mar 2021